DE3586614T2 - Verfahren zur diagnose von krebs. - Google Patents

Verfahren zur diagnose von krebs.

Info

Publication number
DE3586614T2
DE3586614T2 DE8585305362T DE3586614T DE3586614T2 DE 3586614 T2 DE3586614 T2 DE 3586614T2 DE 8585305362 T DE8585305362 T DE 8585305362T DE 3586614 T DE3586614 T DE 3586614T DE 3586614 T2 DE3586614 T2 DE 3586614T2
Authority
DE
Germany
Prior art keywords
diagnosing cancer
diagnosing
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585305362T
Other languages
English (en)
Other versions
DE3586614D1 (de
Inventor
Tatsuya Ishiguro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hitachi Chemical Diagnostics Systems Co Ltd
Original Assignee
Kyowa Medex Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Medex Co Ltd filed Critical Kyowa Medex Co Ltd
Publication of DE3586614D1 publication Critical patent/DE3586614D1/de
Application granted granted Critical
Publication of DE3586614T2 publication Critical patent/DE3586614T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561Immunoelectrophoresis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57476Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofetal proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/813Cancer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/827Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE8585305362T 1984-08-07 1985-07-26 Verfahren zur diagnose von krebs. Expired - Fee Related DE3586614T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59165351A JPH06105257B2 (ja) 1984-08-07 1984-08-07 癌の測定用キット

Publications (2)

Publication Number Publication Date
DE3586614D1 DE3586614D1 (de) 1992-10-15
DE3586614T2 true DE3586614T2 (de) 1993-04-08

Family

ID=15810706

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585305362T Expired - Fee Related DE3586614T2 (de) 1984-08-07 1985-07-26 Verfahren zur diagnose von krebs.

Country Status (7)

Country Link
US (1) US4791066A (de)
EP (1) EP0171243B1 (de)
JP (1) JPH06105257B2 (de)
AU (1) AU584346B2 (de)
CA (1) CA1260388A (de)
DE (1) DE3586614T2 (de)
DK (1) DK169156B1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857457A (en) * 1986-07-24 1989-08-15 Shamsuddin Abulkalam M Screening test for large intestinal cancer
DE3900639A1 (de) * 1988-12-23 1990-06-28 Boehringer Mannheim Gmbh Verfahren zum nachweis von kohlenhydrathaltigen verbindungen und dazu geeignetes reagenz
US5137810A (en) * 1989-04-26 1992-08-11 The University Of North Carolina Method of determining the gram sign of bacteria
US5411868A (en) * 1989-10-24 1995-05-02 Board Of Regents, The University Of Texas System Diagnostic and premonitoring uses of a 65 kDa tumor-associated protein in companion and domestic animal malignancy
DE69115926T2 (de) * 1990-11-30 1996-05-30 Monoclonetics Int Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
FR2679034A1 (fr) * 1991-07-10 1993-01-15 Centre Nat Rech Scient Determination de la malignite des cellules de tumeurs humaines ou animales, au moyen de lectines endogenes.
CA2321160A1 (en) * 1998-02-13 1999-08-19 Oxford Glycosciences (Uk) Ltd. Methods and compositions for diagnosis of hepatoma
US6150123A (en) * 1998-09-03 2000-11-21 Centre Integre De Recherches Biocliniques Sur Le Sida (Cirbs) Affinity biotinylation
GB9919597D0 (en) * 1999-08-18 1999-10-20 Oxford Glycosciences Uk Ltd Methods and compositions for diagnosis of hepatoma
US20030077603A1 (en) * 1999-08-18 2003-04-24 Parekh Rajesh Bhikhu Methods and compositions for diagnosis of hepatoma
US20040115754A1 (en) * 2002-12-11 2004-06-17 Umax Data Systems Inc. Method for establishing a long-term profile of blood sugar level aiding self-control of the same
TW200411178A (en) * 2002-12-31 2004-07-01 Veutron Corp Method for determining the resolution of blood glucose by using rising time curve
US20140274876A1 (en) * 2013-03-15 2014-09-18 Patricia Denny Caries risk test for predicting and assessing the risk of disease
TW592667B (en) * 2003-04-04 2004-06-21 Veutron Corp Method for determining the resolution of blood glucose
GB2404734A (en) * 2003-08-05 2005-02-09 Secr Defence A method of screening a sample for abnormally glycosylated and/or expressed proteins
EP2082234B1 (de) * 2006-11-02 2012-10-03 Procognia (Israel) Ltd. Verfahren zur suche nach therapeutischen molekülen und verwendung der damit erhaltenen moleküle
JPWO2009110517A1 (ja) * 2008-03-04 2011-07-14 味の素株式会社 癌種の評価方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2036308B (en) * 1977-07-14 1982-10-06 Elwing H Method for the determination of enzymes by diffusion in a porous matrix or by electrophoresis
ES488747A0 (es) * 1979-01-30 1981-02-16 Otsuka Pharma Co Ltd Metodo de analizar fluidos corporales.
CH653442A5 (en) * 1982-01-29 1985-12-31 Otsuka Pharma Co Ltd Process for the determination of tumour-associated glucoside derivatives

Also Published As

Publication number Publication date
CA1260388A (en) 1989-09-26
DK357185D0 (da) 1985-08-06
EP0171243B1 (de) 1992-09-09
DE3586614D1 (de) 1992-10-15
AU4565485A (en) 1986-02-13
EP0171243A2 (de) 1986-02-12
US4791066A (en) 1988-12-13
JPH06105257B2 (ja) 1994-12-21
DK169156B1 (da) 1994-08-29
AU584346B2 (en) 1989-05-25
EP0171243A3 (en) 1988-07-27
JPS6144355A (ja) 1986-03-04
DK357185A (da) 1986-02-08

Similar Documents

Publication Publication Date Title
DE3586614D1 (de) Verfahren zur diagnose von krebs.
DE3481453D1 (de) Verfahren zur platzierung von elementen.
DE3582413D1 (de) Verfahren zur reinigung von tantal.
DE3585106D1 (de) Verfahren zur positiven bilderzeugung.
DE3579486D1 (de) Verfahren zur messwertanzeige.
DE3853582T2 (de) Verfahren zur diagnose von leberkrebs oder leberzirrhose.
DE3677091D1 (de) Verfahren zur bestimmung der strahlungsmenge.
DE3586175D1 (de) Photolithographisches verfahren.
DE3575423D1 (de) Verfahren zur herstellung von heteroaryloxyacetamiden.
DE3481144D1 (de) Verfahren zum identifizieren von objekten.
DE3578062D1 (de) Verfahren zur herstellung von iodbenzol.
DE3586154D1 (de) Verbessertes verfahren zur immunofixierungselektrophorese.
DE3765097D1 (de) Verfahren zur fabrikation von basisschmieroelen.
DE3485400D1 (de) Verfahren zur markierung von phagozytischen zellen.
DE3767747D1 (de) Verfahren zum bestimmen von abmessungen.
DE3780593T2 (de) Verfahren zur verhinderung von ablagerungen.
DE3382044D1 (de) Verfahren zur pruefung von freien liganden.
DE3575437D1 (de) Verfahren zur reinigung von farbstoffen.
DE3576148D1 (de) Verfahren zur trennung von racematen.
DE3876806D1 (de) Verfahren zum auslesen von phosphorbildern.
DE3575133D1 (de) Verfahren zur herstellung von 1-alkyl- oder 1-cycloalkylpiperazinen.
DE3676905D1 (de) Verfahren zur detektion von fahrzeugen.
DE3773121D1 (de) Verfahren zum identifizieren gewebstypischer, unloeslicher cytoskelettproteine.
DE3578227D1 (de) Verfahren zur autoradiographie.
DE3673192D1 (de) Verfahren zur bilddarstellung der information.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee